In several human cancers, including melanomas, PI3K and AKT pathways are found to be abnormally activated and are not regulated resulting in the loss of PTEN tumor suppressor functioning, which is interceded due to several mechanisms that block the mutation and gene amplification, and opposes BRAF inhibition [5]. This evidence concerns the gene PIK3CG and melanoma.